FMR1 and fragile X syndrome: Figure 1 shows the [18F]FPEB binding to mGluR5 in one male and one female mouse from each group (FMR1-KO and control); revealing differences in mGluR5 availability between the groups in multiple brain areas known to be impacted in FXS, based on preclinical and clinical studies.